Similar enhancement effects in cell migration were reported following EphA2 expression in other cell types, including MDA-MB-231 breast cancer cells [59], PC3 carcinoma cells [60], U373 glioblastoma cells, and U87 glioblastoma cells [57]. Here, EPHA2 is linked to carcinoma.